This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...
If approved by the EMA, mavorixafor would be the first drug indicated for patients with WHIM syndrome in Europe, a population estimated to be approximately 1,000 people. Earlier this month X4 ...
The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds marbaloxavir and favipiravir while removing amantadine and rimantadine.